Shoulder Innovations, Inc. (SI) EBITDA Margin: -78.37%
Is Shoulder Innovations, Inc.’s EBITDA margin high or low?
Shoulder Innovations, Inc.'s EBITDA margin of -78.37% is 38% below its 2-year average of -56.62%, near the low end of its 2-year range (-78.37%–-38.29%).
As of Sunday, June 21, 2026. 34.36% below its 12-month average of -58.33%.
SI EBITDA Margin Chart
SI Average EBITDA Margin Chart
SI Current vs Average EBITDA Margin Chart
SI EBITDA Margin Metrics
EBITDA MARGIN
-78.37%
EBITDA MARGIN AVG TTM
-58.33%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-34.36%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SI Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | -78.37% | -58.33% | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | -82.07% | -107.48% | -97.90% | -86.99% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | -1.25% | -7.46% | -6.38% | 1.15% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 24.52% | 20.18% | 1.54% | -35.22% |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | -3.34% | -1.19% | -4.96% | -19.15% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 48.39% | -17.53% | -54.94% | 28.49% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 7.60% | 6.80% | 0.29% | -7.92% |
| Tempus AI, Inc. (TEM)vs › | $8.87B | -17.48% | -52.76% | -51.11% | -63.28% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 10.23% | 12.29% | 18.59% | 20.64% |
| Baxter International Inc. (BAX)vs › | $10.27B | 6.81% | 8.65% | 4.13% | 9.00% |
Margin Comparison
Gross Margin
75.5%
EBITDA Margin
-78.4%
Operating Margin
-57.5%
Net Margin
-81.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Shoulder Innovations, Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shoulder Innovations, Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Shoulder Innovations, Inc. (SI)?
- The EBITDA margin for SI stock is -78.37%.
- Is Shoulder Innovations, Inc.'s EBITDA margin high or low?
- Shoulder Innovations, Inc.'s EBITDA margin of -78.37% is 38% below its 2-year average of -56.62%, near the low end of its 2-year range (-78.37%–-38.29%).
- What is the TTM average EBITDA margin for Shoulder Innovations, Inc. (SI)?
- The TTM average EBITDA margin for SI stock is -58.33%.
Shoulder Innovations, Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | -78.37% |
| 2024-12-31 | -38.29% |
| 2023-12-31 | -53.20% |
Related Metrics
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane